TWiV explains studies showing that SARS-CoV-2 mRNA vaccines improve life span of cancer patients on checkpoint immunotherapy, and broad immunity conferred by a vaccine central in A(H5) influenza antigenic space.

Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Kathy Spindler

Subscribe (free): Apple Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

Support science education at MicrobeTV
Immune 100 live at the Incubator
SARS-CoV-2 mRNA vaccines sensitize tumors to checkpoint immunotherapy (Nature)
People with some cancers live longer after mRNA vaccines (Nature)
Immune checkpoint inhibitors (NCI)
Broad immunity from influenza H5 vaccine (Nature)
Derek Smith on antigenic cartography (TWiV 99 at 2:53)
Letters read on TWiV 1265
Timestamps by Jolene Ramsey. Thanks!

Weekly Picks

Kathy – Permethrin-treated baby wraps for malaria prevention and Phil Sharp and the Biotech Revolution Rich – Lydia Fairchild; Tetragametic Chimerism (NEJM) Alan – Warning Signs Vincent – radio.garden thanks to Kim!

Listener Pick

Jamie – SkyCards by Flightradar24

Intro music is by Ronald Jenkees

Send your virology questions and comments to twiv@microbe.tv

Content in this podcast should not be construed as medical advice.

TWiV 1265: mRNA vaccines make cancer treatment great again

This Week in Virology

Vaccination increases tumor PD‑L1 and may alter treatment decisions

The AI-powered Podcast Player